Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer have?
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer has 194 citations in the OpenAlex counts ScholarIQ stores.
When was Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer published?
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer has 2020 year in the ScholarIQ index.
What is the open-access status of Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer?
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer has gold oa status in the ScholarIQ index.
What is the DOI of Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer?
The DOI for Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer is on the source record.
What is the PMID of Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer?
The PMID for Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer is on the source record.
What is the OpenAlex record for Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer?
The OpenAlex for Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer is on the source record.